According to Prometheus Biosciences's latest financial reports the company's current EPS (TTM) is -$3.52. In 2022 the company made an earnings per share (EPS) of -$3.48 an increase over its 2021 EPS that were of -$3.63.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.52 | 1.15% |
2022 | -$3.48 | -4.13% |
2021 | -$3.63 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Akebia Therapeutics AKBA | -$0.64 | -81.82% | ๐บ๐ธ USA |
![]() Agenus
AGEN | -$0.85 | -75.85% | ๐บ๐ธ USA |